HPV vaccine talk shifts from fanfare to fear

Two years after the vaccine's approval, concerns about safety and the drug's marketing are raising questions in exam rooms.
Posted in Health Insurance, Healthcare, Medicare |

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.